CFDB - Cystic Fibrosis DataBase

ongoing trials trial from

Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis - Phase 1|Phase 2 - Not yet recruiting

Study design (if review, criteria of inclusion for studies)

Interventional - Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment


Cystic Fibrosis - 18 Years and older   (Adult, Senior)


Drug: MRT5005|Drug: Normal saline

Outcome measures

Types, frequency and severity of treatment-emergent Adverse Events|Delivery of mRNA

Keywords: Adult; Adolescent; CFTR Modulators; Genetic Predisposition to Disease; pharmacological_intervention; MRT5005;